确诊COVID-19病例中基础健康状况与住院、死亡及院内死亡的年龄特异性关联:基于监测数据的多国研究,2020年6月至12月
该研究分析九个欧洲国家2020年6月2日至12月13日提交至欧洲监测系统的COVID-19病例数据,估计基础疾病与住院、死亡及院内死亡的年龄特异性关联。癌症、心脏病、糖尿病、免疫缺陷、肾脏、肝脏和肺部疾病、神经系统疾病及肥胖与住院和死亡风险升高相关(aOR 1.5-5.6)。随年龄增长,年龄特异性aOR降低而预测概率升高;多病共存患者中,重症aOR随基础疾病数量增加而升高。
要点
- 癌症、心脏病、糖尿病、免疫缺陷、肾脏、肝脏和肺部疾病、神经系统疾病及肥胖与住院和死亡风险升高相关(aOR 1.5-5.6)。
- 随年龄增长,年龄特异性aOR降低而预测概率升高;部分疾病年轻患者的预测概率至少与无该病的老年病例相当。
- 多病共存患者中,重症aOR随基础疾病数量增加而升高,所有结局和所有年龄组均如此。
核心结论
- 研究结果支持基于年龄的疫苗推广,并可为更细致的年龄和疾病特异性疫苗优先策略提供信息;这在各国考虑为年轻人接种、加强针和剂量间隔以应对疫苗逃逸变异株时具有相关性。
研究设计与样本
- 分析九个欧洲国家2020年6月2日至12月13日提交至欧洲监测系统的基于病例的COVID-19数据。
- 暴露为仅有单一基础疾病的病例中的11种基础疾病,以及多病共存病例中基础疾病的数量。
- 使用39个不同的年龄调整和年龄交互多变量logistic回归模型估计调整比值比(aOR),并用后者的边际均值估计每种疾病-年龄组组合的严重结局概率。
主要发现
- 控制年龄、性别、报告期和国家后,癌症、心脏病、糖尿病、免疫缺陷、肾脏、肝脏和肺部疾病、神经系统疾病及肥胖与住院和死亡风险升高相关(aOR 1.5-5.6)。
- 随年龄增长,年龄特异性aOR降低而预测概率升高。
- 对于某些疾病,年轻患者中的预测概率至少与无该病的老年病例一样高。
- 多病共存患者中,所有结局和所有年龄组的重症aOR均随基础疾病数量增加而升高。
临床怎么用
- 研究结果支持基于年龄的疫苗推广,并可为更细致的年龄和疾病特异性疫苗优先策略提供信息。
- 作者认为,这在各国考虑为年轻人接种、加强针和剂量间隔以应对疫苗逃逸变异株时具有相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundUnderlying conditions are risk factors for severe COVID-19 outcomes but evidence is limited about how risks differ with age.AimWe sought to estimate age-specific associations between underlying conditions and hospitalisation, death and in-hospital death among COVID-19 cases.MethodsWe analysed case-based COVID-19 data submitted to The European Surveillance System between 2 June and 13 December 2020 by nine European countries. Eleven underlying conditions among cases with only one condition and the number of underlying conditions among multimorbid cases were used as exposures. Adjusted odds ratios (aOR) were estimated using 39 different age-adjusted and age-interaction multivariable logistic regression models, with marginal means from the latter used to estimate probabilities of severe outcome for each condition-age group combination.ResultsCancer, cardiac disorder, diabetes, immunodeficiency, kidney, liver and lung disease, neurological disorders and obesity were associated with elevated risk (aOR: 1.5-5.6) of hospitalisation and death, after controlling for age, sex, reporting period and country. As age increased, age-specific aOR were lower and predicted probabilities higher. However, for some conditions, predicted probabilities were at least as high in younger individuals with the condition as in older cases without it. In multimorbid patients, the aOR for severe disease increased with number of conditions for all outcomes and in all age groups.ConclusionWhile supporting age-based vaccine roll-out, our findings could inform a more nuanced, age- and condition-specific approach to vaccine prioritisation. This is relevant as countries consider vaccination of younger people, boosters and dosing intervals in response to vaccine escape variants.
引用
- Funk T, Innocenti F, Gomes Dias J, et al. Age-specific associations between underlying health conditions and hospitalisation, death and in-hospital death among confirmed COVID-19 cases: a multi-country study based on surveillance data, June to December 2020. Euro Surveill. 2022. PMID: 36052721. doi:10.2807/1560-7917.ES.2022.27.35.2100883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。